Predicted to enable NF-kappaB binding activity and cyclin-dependent protein serine/threonine kinase inhibitor activity. Predicted to act upstream of or within positive regulation of NF-kappaB transcription factor activity and positive regulation of cytokine production involved in inflammatory response. Predicted to be active in nucleus. Orthologous to human ANKRD42 (ankyrin repeat domain 42).
RGD Description
Predicted to enable NF-kappaB binding activity. Predicted to act upstream of or within positive regulation of NF-kappaB transcription factor activity and positive regulation of cytokine production involved in inflammatory response. Predicted to be active in nucleus. Orthologous to human ANKRD42 (ankyrin repeat domain 42); INTERACTS WITH 2,4-dinitrotoluene; 6-propyl-2-thiouracil; acrylamide.